Showing 8 results for Researcher: Dan W. Stracener
February 18, 2026
2 MIN READ
Experiments conducted between 2002 and 2012 at ORNL studied 31 tin isotopes with varying numbers of neutrons to examine how neutrons affect nuclear stability and nuclear properties. The combined results contributed to identifying tin-132 as a doubly magic nucleus and improved theoretical models of nuclear structure.
February 28, 2024
6 MIN READ
Two different teams that included Oak Ridge National Laboratory employees were honored Feb. 20 with Secretary’s Honor Achievement Awards from the Department of Energy. This is DOE's highest form of employee recognition.
November 17, 2021
6 MIN READ
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.
August 26, 2021
2 MIN READ
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
August 2, 2021
1 MIN READ
An Oak Ridge National Laboratory researcher has invented a version of an isotope-separating device that can withstand extreme environments, including radiation and chemical solvents.
June 2, 2020
1 MIN READ
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
February 1, 2020
2 MIN READ
Scientists from ORNL and several Japanese laboratories have developed an experimental method for fast determination of the optimum heavy-ion beam energy for the synthesis of super heavy elements.
May 31, 2018
4 MIN READ
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.